期刊文献+

清营泻热化瘀汤治疗早期深静脉血栓形成的临床观察 被引量:11

Clinical observation of Qingying Xiere Huayu Decoction in the treatment of early deep venous thrombosis
下载PDF
导出
摘要 目的观察清营泻热化瘀汤治疗早期深静脉血栓形成的临床疗效。方法将60例早期深静脉血栓形成患者随机分为治疗组与对照组,每组30例。两组均予常规基础护理,治疗组加服清营泻热化瘀汤,对照组加用低分子肝素钙。两组疗程均为14天,观察临床疗效,比较相关生化指标(血小板计数、凝血酶原时间、D-二聚体水平)、下肢周径的变化情况。结果 (1)治疗组、对照组临床总有效率分别为93.33%和83.33%;组间临床疗效比较,治疗组显著优于对照组(P<0.05)。(2)组间治疗后比较,血小板计数、凝血酶原时间差异无统计学意义(P>0.05),而D-二聚体水平治疗组较对照组下降更加显著(P<0.05)。(3)组间治疗后比较,治疗组下肢(踝段、腓中、髌上10 cm、股中)周径缩短程度较对照组更加明显(P<0.05)。结论清营泻热化瘀汤治疗早期深静脉血栓形成的疗效满意,可显著减轻下肢肿胀及疼痛,改善患者的血液高凝状态。 Objective To observe the clinical efficacy of Qingying Xiere Huayu Decoction in the treatment of early deep venous thrombosis. Methods 60 patients with early deep venous thrombosis were randomly divided into the treatment group and control group,30 cases in each group. Both groups were given the routine basic nursing. In addition, the treatment group was treated with Qingying Xiere Huayu Decoction and the control group was treated with low molecular weight heparin, with a course of 14 days. The clinical efficacy was observed, the changes of related biochemical parameters ( platelet count, prothrombin time and D-dimer) and circumference of lower limbs were compared. Results (1)The clinical total effective rate was 93.33% in the treatment group and 83.33% in the control group. The clinical efficacy of the treatment group was significantly better than that of the control group ( P 〈 0.05 ) . (2)After treatment, there were no statistically significant differences on the platelet count and prothrombin time between the two groups( P 〉 0.05 ), but the decrease of D-dimer level in the treatment group were more greater than those in the control group (P 〈 0.05 ) . (3)After treatment, the reduction of circumference of lower limbs ( ankle, fibula, 10cm above patella and femur) in the treatment group were more significant than those in the control group ( P 〈 0.05 ) . Conclusion Qingying Xiere Huayu Decoction shows good efficacy in the treatment of early deep venous thrombosis, which can significantly alleviate the swelling and pain of lower limbs, and improve the blood hypercoagulable state of patients.
出处 《上海中医药杂志》 2017年第6期67-70,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市科委自然科学基金计划资助项目(17ZR1427600) 上海市虹口区卫计委医学科研课题计划资助项目(虹卫1602-01)
关键词 深静脉血栓形成 急性期 亚急性期 股肿 清营泻热化瘀 血液高凝状态 deep venous thrombosis acute stage subacute stage thigh swelling Qingying Xiere Huayu Decoction blood hypercoagulable state
  • 相关文献

参考文献4

二级参考文献20

  • 1孙敏莉,张柏根.急性下肢深静脉血栓形成治疗的选择及评价[J].中国实用外科杂志,2006,26(10):756-758. 被引量:31
  • 2张皓,张柏根,奚九一,赵兆琳.软坚清脉方抗动脉粥样硬化的预防效用研究[J].中国中西医结合外科杂志,1996,2(5):334-338. 被引量:4
  • 3张皓,张柏根,奚九一,赵兆琳.软坚清脉方抗动脉粥样硬化的治疗效用研究[J].中国中西医结合外科杂志,1996,2(6):405-409. 被引量:4
  • 4奚九一,王健,赵兆琳,王玉琦,符伟国.软坚清脉方抗肢体动脉粥样硬化的临床研究[J].上海中医药杂志,1997,31(1):2-5. 被引量:18
  • 5冯友贤.血管外科学[M].第二版,上海:上海科学技术出版社.
  • 6Cohen AT, Agnelli G, Anderson FA, et al.Venous thromboembo- lism (~TE) in Europe. The number of YTE events and associated morbidity and mortality [J].Thromb Haemost, 2007, 98(4): 756-764.
  • 7Kahn SR, Shrier I, Julian JA, et al.Detemfinants and time course of the postthrombotic syndrome after acute deep venous throm- bosis [J ] .Ann Intern Med,2008,149(10): 698-707.
  • 8Kearon C, Akl EA, Cemerota AJ, et aLAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evi- dence-Based Clinical Practice Guidelines [J].Chest,2012, 141 (suppl) : 419-494.
  • 9Howard LS, Hughes RJ.NICE guideline : management of venous thromboembolic diseases and role of thrombophilia testing [J]. Thorax,2013, 68 : 391-393.
  • 10Perzborn E, Roehrig S, Straub A, et al. Rivaroxaban: a new oral factor Xa inhibitor [J].Arterioscler Thromb Vasc Biol,2010, 30: 376-381.

共引文献279

同被引文献149

引证文献11

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部